Abstract
Dominant-negative CDK13 mutations cause oncogenic deficiencies in RNA surveillance.
©2023 American Association for Cancer Research
2023
American Association for Cancer Research
You do not currently have access to this content.
Advertisement
Mutant CDK13 Triggers Oncogenic RNA Processing Defects in Melanoma. Cancer Discov 1 July 2023; 13 (7): 1508. https://doi.org/10.1158/2159-8290.CD-RW2023-068
Download citation file:
Dominant-negative CDK13 mutations cause oncogenic deficiencies in RNA surveillance.
Advertisement